Christopher Pittenger

Christopher Pittenger

Auto-generated profile, based on publicly available information

Christopher Pittenger

Department of Psychiatry, Yale University, New Haven, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2007 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
CPChristopher Pittenger
Christopher Pittenger
RDRonald S Duman
Ronald S Duman
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.

1 December 2008 in American Journal of Psychiatry
Verified
Journal Article
Closed access
MBMichael H. Bloch
Michael H. Bloch
ALAngeli Landeros-Weisenberger
Angeli Landeros-Weisenberger
MRMaria C. Rosario
Maria C. Rosario
CPChristopher Pittenger
Christopher Pittenger
JLJames F. Leckman
James F. Leckman

1 June 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TTTerrence Town
Terrence Town
YLYasmina Laouar
Yasmina Laouar
CPChristopher Pittenger
Christopher Pittenger
TMTakashi Mori
Takashi Mori
CSChristine A Szekely
Christine A Szekely
RFRichard A Flavell
Richard A Flavell

1 April 2002 in Neuron
Verified
Journal Article
Closed access
CPChristopher Pittenger
Christopher Pittenger
YHYan You Huang
Yan You Huang
RPRonald F. Paletzki
Ronald F. Paletzki
RBRoussoudan Bourtchouladze
Roussoudan Bourtchouladze
HSHeather Scanlin
Heather Scanlin
EKEric R. Kandel
Eric R. Kandel

1 December 2011 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
CPChristopher Pittenger
Christopher Pittenger
MBMichael H. Bloch
Michael H. Bloch
KWKyle Williams
Kyle Williams

14 August 2012 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
SSS. Evelyn Stewart
S. Evelyn Stewart
DYD Yu
D Yu
JSJ M Scharf
J M Scharf
BNB M Neale
B M Neale
JFJ A Fagerness
J A Fagerness
DPD L Pauls
D L Pauls
Obsessive-compulsive disorder (OCD) is a common, debilitating neuropsychiatric illness with complex genetic etiology. The International OCD Foundation Genetics Collaborative (IOCDF-GC) is a multi-national collaboration established to discover the genetic variation predisposing to OCD. A set of individuals affected with DSM-IV OCD, a subset of their parents, and unselected controls, were genotyped with several different Illumina SNP microarrays. After extensive data cleaning, 1465 cases, 5557 ancestry-matched controls and 400 complete trios remained, with a common set of 469 410 autosomal and 9657 X-chromosome single nucleotide polymorphisms (SNPs). Ancestry-stratified case–control association analyses were conducted for three genetically-defined subpopulations and combined in two meta-analyses, with and without the trio-based analysis. In the case–control analysis, the lowest two P-values were located within DLGAP1 (P=2.49 × 10−6 and P=3.44 × 10−6), a member of the neuronal postsynaptic density complex. In the trio analysis, rs6131295, near BTBD3, exceeded the genome-wide significance threshold with a P-value=3.84 × 10−8. However, when trios were meta-analyzed with the case–control samples, the P-value for this variant was 3.62 × 10−5, losing genome-wide significance. Although no SNPs were identified to be associated with OCD at a genome-wide significant level in the combined trio–case–control sample, a significant enrichment of methylation QTLs (P<0.001) and frontal lobe expression quantitative trait loci (eQTLs) (P=0.001) was observed within the top-ranked SNPs (P<0.01) from the trio–case–control analysis, suggesting these top signals may have a broad role in gene expression in the brain, and possibly in the etiology of OCD.